DVL2 and acute myeloid leukemia: Upon Wnt ligands binding to Fzd receptors, DVL2 disassembles the degradation complex, thus stabilizing β‐catenin.[8] While accumulating evidence shows the importance of β‐catenin in regulating LSC function, little is known about the role and regulatory mechanism of DVL2 in LSC of AML.[9]